Company research
DIVERSIFIED HEALTHCARE TRUST
CIK 1075415Updated Sep 25, 2026
Name history
SENIOR HOUSING PROPERTIES TRUST · through Nov 7, 2019
DHC price & chart
Loading TradingView…
NASDAQ:DHC on TradingView ↗About the company
DHC is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of June 30, 2025, DHC’s approximately $6.8 billion portfolio included 341 properties in 34 states and Washington, D.C., with more than 26,000 senior living units, approximately 7.4 million square feet of medical office and life science properties and occupied by approximately 450 tenants. DHC is managed by The RMR Group (Nasdaq: RMR), a leading U.S. alternative asset management company with approximately $40 billion in assets under management as of June 30, 2025 and more than 35 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, MA. For more information, visit www.dhcreit.com.
In the news
No coverage from other publishers is available.
Recent filings
4 filing
SCHEDULE 13G/A filing
SCHEDULE 13D/A filing
10-Q filing
Results of Operations and Financial Condition
Items 2.02, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 4,361,250,000Source | 5,137,005,000Source | 5,446,136,000Source | 6,002,093,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 105,407,000Source | 144,584,000Source | 245,939,000Source | 658,065,000Source |
| Operating Lease, Right-of-Use AssetUSD | 16,537,000Source | 20,025,000Source | 23,366,000Source | 26,508,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 2,695,682,000Source | 3,178,162,000Source | 3,109,245,000Source | 3,363,482,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 2,421,000Source | 2,413,000Source | 2,405,000Source | 2,397,000Source |
| Retained Earnings (Accumulated Deficit)USD | 1,122,137,000Source | 1,408,023,000Source | 1,778,278,000Source | 2,071,850,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -12,000Source | -17,000Source | — | — |
| Stockholders' Equity Attributable to ParentUSD | 1,665,568,000Source | 1,958,843,000Source | 2,336,891,000Source | — |
| Additional Paid in Capital, Common StockUSD | 4,622,572,000Source | 4,620,313,000Source | 4,618,470,000Source | 4,617,031,000Source |
| Liabilities and EquityUSD | 4,361,250,000Source | 5,137,005,000Source | 5,446,136,000Source | 6,002,093,000Source |
| Additional Financial Items | ||||
| Long-term DebtUSD | 2,444,116,000Source | 3,050,336,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -293,572,000Source | -15,774,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 261,923,000Source | 284,957,000Source | 284,083,000Source | 239,280,000Source |
| Deferred Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -19,618,000Source | 112,223,000Source | 10,483,000Source | -40,353,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | 483,572,000Source | -187,019,000Source | -202,111,000Source | 387,708,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 1,145,000Source | 904,000Source | 393,000Source | 171,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -492,009,000Source | -22,311,000Source | -249,713,000Source | -675,998,000Source |
| Payments of Ordinary Dividends, Common StockUSD | 9,661,000Source | 9,627,000Source | 9,595,000Source | 9,568,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -28,055,000Source | -97,107,000Source | -441,341,000Source | -328,643,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 121,799,000Source | 149,854,000Source | 246,961,000Source | 688,302,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 271,834,000Source | 131,557,000Source | 186,534,000Source | 201,153,000Source |
| Income Taxes Paid, NetUSD | 1,776,000Source | — | — | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 3,411,000Source | 2,747,000Source | 1,840,000Source | 1,733,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 77,942,000Source | 103,437,000Source | 11,811,000Source | 8,658,000Source |
| DepreciationUSD | 261,923,000Source | 284,957,000Source | 284,083,000Source | 239,280,000Source |
| Equity Securities, FV-NI, Gain (Loss)USD | 0Source | 0Source | 8,126,000Source | -25,660,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | 0Source | 0Source | 8,126,000Source | -25,660,000Source |
| Gain (Loss) on Sale of PropertiesUSD | 117,730,000Source | -18,938,000Source | 1,205,000Source | 321,862,000Source |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | 0Source |
| Gain (Loss) on Extinguishment of DebtUSD | -42,526,000Source | -324,000Source | -2,468,000Source | -30,043,000Source |
| General and Administrative ExpenseUSD | 45,502,000Source | 26,518,000Source | 26,131,000Source | 26,435,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 36,760,000Source | 1,597,000Source | -20,461,000Source | 6,055,000Source |
| Income Tax Expense (Benefit)USD | 1,743,000Source | 467,000Source | 445,000Source | 710,000Source |
| Insured Event, Gain (Loss)USD | — | — | — | -7,635,000Source |
| InterestExpenseNonoperatingUSD | 204,498,000Source | 235,239,000Source | — | — |
| Marketable Securities, Unrealized Gain (Loss)USD | — | — | 8,126,000Source | -25,660,000Source |
| Net Income (Loss) Attributable to ParentUSD | -285,886,000Source | -370,255,000Source | -293,572,000Source | -15,774,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source |
| Operating Costs and ExpensesUSD | 1,259,340,000Source | 1,236,542,000Source | 1,174,151,000Source | 1,109,070,000Source |
| Payments of Financing CostsUSD | 22,227,000Source | 8,562,000Source | 21,699,000Source | 2,817,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 1,537,853,000Source | 1,495,427,000Source | 1,410,308,000Source | 1,283,566,000Source |
| Income Tax Expense (Benefit)USD | 1,743,000Source | 467,000Source | 445,000Source | 710,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -285,886,000Source | -370,255,000Source | -293,572,000Source | -15,774,000Source |
| Earnings Per Share, BasicUSD per share | -1.19Source | -1.55Source | -1.23Source | -0.07Source |
| Earnings Per Share, DilutedUSD per share | -1.19Source | -1.55Source | -1.23Source | -0.07Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 240,286,000Source | 239,535,000Source | 238,836,000Source | 238,314,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 240,286,000Source | 239,535,000Source | 238,836,000Source | 238,314,000Source |
| Interest Expense (non-operating)USD | 204,498,000Source | 235,239,000Source | — | — |
| Additional Financial Items | ||||
| Business Combination, Acquisition Related CostsUSD | 10,356,000Source | 2,510,000Source | 10,853,000Source | 2,605,000Source |
| Costs and ExpensesUSD | 1,742,823,000Source | 1,621,261,000Source | 1,513,598,000Source | 1,377,390,000Source |
| Current Income Tax Expense (Benefit)USD | 1,743,000Source | 467,000Source | 445,000Source | 710,000Source |
| Equity Securities, FV-NI, Realized Gain (Loss)USD | 0Source | 0Source | 8,126,000Source | -25,660,000Source |
| General and Administrative ExpenseUSD | 45,502,000Source | 26,518,000Source | 26,131,000Source | 26,435,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | 36,760,000Source | 1,597,000Source | -20,461,000Source | 6,055,000Source |
| Interest and Other IncomeUSD | 5,839,000Source | 8,950,000Source | 15,536,000Source | 15,929,000Source |
| Interest ExpenseUSD | — | — | 191,775,000Source | 209,383,000Source |
| Operating Costs and ExpensesUSD | 1,259,340,000Source | 1,236,542,000Source | 1,174,151,000Source | 1,109,070,000Source |
Filing attachments
tm2616535d1_ex99-1.htm · 8-K · 2026-06-01
EX-99.1 2 tm2616535d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 1 1 Investor Presentation June 2026 ──────────────── 2 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”, “will”, “may” and negatives or derivatives of these…
Read attachment ↗tm2613539d1_ex99-1.htm · 8-K · 2026-05-05
EX-99.1 2 tm2613539d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 1 1 Investor Presentation Overture at Plano 500 Coit Road Plano, TX May 2026 ───────────────────── 2 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estimate”,…
Read attachment ↗tm267110d1_ex99-1.htm · 8-K · 2026-02-24
EX-99.1 2 tm267110d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 1 1 Investor Presentation Overture at Plano 500 Coit Road Plano, TX February 2026 ───────────────────── 2 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estima…
Read attachment ↗tm2532991d1_ex99-1.htm · 8-K · 2025-12-08
EX-99.1 2 tm2532991d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 1 1 Investor Presentation Overture at Plano 500 Coit Road Plano, TX December 2025 ───────────────────── 2 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as “believe”, “expect”, “anticipate”, “intend”, “plan”, “estim…
Read attachment ↗tm2528229d1_ex99-1.htm · 8-K · 2025-10-08
EX-99.1 2 tm2528229d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 1 1 Investor Presentation Overture at Plano 500 Coit Road Plano, TX Updated October 2025 ──────────────────────── 2 2 This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other securities laws that are subject to risks and uncertainties. These statements may include words such as “believe”, “expect”, “anticipate”, “intend”, “pla…
Read attachment ↗tm2526908d1_ex4-1.htm · 8-K · 2025-09-29
EX-4.1 2 tm2526908d1_ex4-1.htm EXHIBIT 4.1 Exhibit 4.1 Execution Version DIVERSIFIED HEALTHCARE TRUST THE SUBSIDIARY GUARANTORS NAMED HEREIN and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, as Trustee and Collateral Agent Dated as of September 26, 2025 $375,000,000 7.250% Senior Secured Notes due 2030 TABLE OF CONTENTS Page ARTICLE One Definitions and Other Provisions of General Application 1 Section 1.01. …
Read attachment ↗